← Back to Screener
SIGA Technologies Inc. (SIGA)
Price$4.57
Favorite Metrics
Price vs S&P 500 (26W)-50.84%
Price vs S&P 500 (4W)-13.14%
Market Capitalization$327.41M
P/E Ratio (Annual)14.06x
Indicated Dividend Yield (Annual)0.00%
All Metrics
P/CF (Annual)7.53x
Book Value / Share (Quarterly)$2.78
P/TBV (Annual)20.08x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-5.14%
Cash Flow / Share (Quarterly)$0.60
Payout Ratio (TTM)120.81%
Price vs S&P 500 (YTD)-26.23%
Gross Margin (TTM)68.59%
Net Profit Margin (TTM)24.61%
EPS (TTM)$0.32
10-Day Avg Trading Volume0.74M
EPS Excl Extra (TTM)$0.32
Revenue Growth (5Y)-5.43%
EPS (Annual)$0.32
Dividend / Share (Annual)$0.60
ROI (Annual)11.71%
Gross Margin (Annual)68.59%
Net Profit Margin (5Y Avg)39.71%
Cash / Share (Quarterly)$2.16
P/E Basic Excl Extra (TTM)14.06x
Revenue Growth QoQ (YoY)-95.34%
EPS Growth (5Y)-14.51%
P/E Normalized (Annual)14.06x
ROA (Last FY)10.61%
Revenue Growth TTM (YoY)-31.82%
EBITD / Share (TTM)$0.43
ROE (5Y Avg)26.70%
Operating Margin (TTM)25.06%
Cash Flow / Share (Annual)$0.60
P/B Ratio1.65x
P/B Ratio (Quarterly)2.20x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.82x
Net Interest Coverage (TTM)12.31x
ROA (TTM)9.98%
EV / EBITDA (TTM)5.57x
EPS Incl Extra (Annual)$0.32
Current Ratio (Annual)11.83x
Quick Ratio (Quarterly)8.79x
3-Month Avg Trading Volume0.55M
52-Week Price Return-19.59%
EV / Free Cash Flow (Annual)4.00x
P/E Incl Extra (TTM)14.06x
Revenue / Employee (TTM)$2
Tangible BV / Share (Quarterly)$0.15
P/S Ratio (Annual)3.46x
Asset Turnover (Annual)0.43x
52-Week High$9.62
Operating Margin (5Y Avg)48.09%
EPS Excl Extra (Annual)$0.32
CapEx CAGR (5Y)77.76%
Tangible BV CAGR (5Y)19.88%
26-Week Price Return-42.09%
Quick Ratio (Annual)8.79x
13-Week Price Return-29.17%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)11.83x
Enterprise Value$172.449
Revenue / Share Growth (5Y)-3.52%
Asset Turnover (TTM)0.41x
Book Value / Share Growth (5Y)10.55%
Revenue / Employee (Annual)$2
Inventory Turnover (Annual)0.60x
Pretax Margin (Annual)32.12%
Cash / Share (Annual)$2.16
3-Month Return Std Dev49.05%
Gross Margin (5Y Avg)82.36%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-17.41%
ROE (Last FY)11.71%
Net Interest Coverage (Annual)70.15x
EPS Basic Excl Extra (Annual)$0.32
P/FCF (TTM)2.59x
Receivables Turnover (TTM)7.74x
EV / Free Cash Flow (TTM)4.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.32
Receivables Turnover (Annual)7.74x
ROI (TTM)11.25%
P/S Ratio (TTM)3.46x
Pretax Margin (5Y Avg)51.26%
Revenue / Share (Annual)$1.32
Tangible BV / Share (Annual)$0.15
Forward P/E2.69x
Free OCF CAGR (5Y)-9.62%
Price vs S&P 500 (52W)-54.69%
P/E Ratio (TTM)14.06x
EPS Growth TTM (YoY)-60.79%
Year-to-Date Return-22.09%
5-Day Price Return6.73%
EPS Normalized (Annual)$0.32
ROA (5Y Avg)22.27%
Net Profit Margin (Annual)24.61%
Month-to-Date Return-11.03%
Cash Flow / Share (TTM)$-0.06
EBITD / Share (Annual)$0.43
EPS Growth (3Y)-11.11%
Operating Margin (Annual)25.06%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)7.53x
ROI (5Y Avg)26.70%
P/E Excl Extra (TTM)14.06x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$0.32
P/TBV (Quarterly)20.08x
Payout Ratio (Annual)185.22%
P/B Ratio (Annual)2.20x
Dividend / Share (TTM)$0.60
Inventory Turnover (TTM)0.60x
Pretax Margin (TTM)32.12%
Book Value / Share (Annual)$2.78
Price vs S&P 500 (13W)-32.03%
Net Margin Growth (5Y)-11.39%
Dividend Yield (TTM)13.17%
Beta0.92x
P/FCF (Annual)7.59x
Revenue / Share (TTM)$1.32
ROE (TTM)11.25%
52-Week Low$4.29
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
SIGASIGA Technologies Inc. | 3.46x | -31.82% | 68.59% | -14.51% | $4.57 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
SIGA Technologies is a commercial-stage pharmaceutical company focused on health security solutions. Its flagship product, TPOXX, is an oral antiviral treatment for human smallpox caused by the variola virus. The company derives its revenue primarily from the United States market.